Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From Danone

Wellness Industry News: Acting FDA Commissioner Named, Thorne Test Line Grows, Nitrosigine In Revel Energy, More

NCI's Sharpless named acting FDA head; Mannatech trims loss as costs grow; Nilo drinks to avoiding hangovers; Daoust leads Soylent Nutrition development, innovation; Viactiv in taller, narrower package; Revel Energy made with Nitrosigine; and Thorne has at-home tests for additional concerns.

Wellness Advertising, Marketing & Sales

Seventure Reaffirms Microbiome Confidence With New €200m Fund

With its first microbiome fund completing its investment period, French venture capitalist Seventure Partners has raised more than €100m of a €200m target for its second microbiome-focused fund.

Financing StartUps and SMEs

Coty’s New Leadership Revives Investor Confidence; Now Consumer Biz Must ‘Earn Right To Grow’

Coty’s improved second-quarter results, and Pierre Laubies’ remarks in his first earnings call as the company’s chief exec, charmed the investment community, though a detailed strategy from management – including its plan for the ailing Consumer Beauty unit – is still to come.
Beauty Business Strategies

GSK’s Horlicks Review Plan - Some Early Expectations In India

A potential sale of Horlicks could impact market dynamics significantly in India where the popular malt beverage holds a dominant position but has seen competition build up. GlaxoSmithKline, though, has underscored that the review plan had nothing to do with the product’s "critical mass".
Commercial Strategy
See All

Company Information

  • Industry
  • Diversified
  • Pharmaceuticals
    • Nutraceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Groupe Danone
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Danone
  • Senior Management
  • Pierre-Andre Terisse, EVP, Fin.
  • Contact Info
  • Danone
    Phone: 144 352020
    15 Rue du Helder
    Paris, 75 439
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register